Cargando…

Progressive natural killer cell dysfunction associated with alterations in subset proportions and receptor expression in soft-tissue sarcoma patients

Immunotherapy is currently investigated as treatment option in many types of cancer. So far, results from clinical trials have demonstrated that significant benefit from immunomodulatory therapies is restricted to patients with select histologies. To broaden the potential use of these therapies, a d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bücklein, Veit, Adunka, Tina, Mendler, Anna N., Issels, Rolf, Subklewe, Marion, Schmollinger, Jan C., Noessner, Elfriede
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5006893/ https://www.ncbi.nlm.nih.gov/pubmed/27622032 http://dx.doi.org/10.1080/2162402X.2016.1178421

Ejemplares similares

Ifosfamide, Carboplatin, and Etoposide (ICE) in Combination with Regional Hyperthermia as Salvage Therapy in Patients with Locally Advanced Nonmetastatic and Metastatic Soft-Tissue Sarcoma
por: Bücklein, Veit, et al.
Publicado: (2020)

T-cell-based immunotherapy of acute myeloid leukemia: current concepts and future developments
por: Daver, Naval, et al.
Publicado: (2021)

The PI3K∂-Selective Inhibitor Idelalisib Induces T- and NK-Cell Dysfunction Independently of B-Cell Malignancy-Associated Immunosuppression
por: Rohrbacher, Lisa, et al.
Publicado: (2021)

Intratumoral alterations of dendritic-cell differentiation and CD8(+) T-cell anergy are immune escape mechanisms of clear cell renal cell carcinoma
por: Noessner, Elfriede, et al.
Publicado: (2012)

VISTA in Soft Tissue Sarcomas: A Perspective for Immunotherapy?
por: Albertsmeier, Markus, et al.
Publicado: (2022)

Double Strike Approach for Tumor Attack: Engineering T Cells Using a CD40L:CD28 Chimeric Co-Stimulatory Switch Protein for Enhanced Tumor Targeting in Adoptive Cell Therapy
por: Olguín-Contreras, Luis Felipe, et al.
Publicado: (2021)

Cancer Testis Antigens and Immunotherapy: Expression of PRAME Is Associated with Prognosis in Soft Tissue Sarcoma
por: Albertsmeier, Markus, et al.
Publicado: (2020)

Tumor Lactic Acidosis: Protecting Tumor by Inhibiting Cytotoxic Activity Through Motility Arrest and Bioenergetic Silencing
por: Fischbeck, Angelika J., et al.
Publicado: (2020)

DGK-α: A Checkpoint in Cancer-Mediated Immuno-Inhibition and Target for Immunotherapy
por: Noessner, Elfriede
Publicado: (2017)

The Role of Natural Killer Cells in Soft Tissue Sarcoma: Prospects for Immunotherapy
por: Fortes-Andrade, Tânia, et al.
Publicado: (2021)

Integrated multiomic approach for identification of novel immunotherapeutic targets in AML
por: Köhnke, Thomas, et al.
Publicado: (2022)

Activity of cytokine-induced killer cells against bone and soft tissue sarcoma
por: Sangiolo, Dario, et al.
Publicado: (2014)

A Novel CXCL10-Based GPI-Anchored Fusion Protein as Adjuvant in NK-Based Tumor Therapy
por: Muenchmeier, Niklas, et al.
Publicado: (2013)

Cord Blood Vα24-Vβ11(+) Natural Killer T Cells Display a Th2-Chemokine Receptor Profile and Cytokine Responses
por: Harner, Susanne, et al.
Publicado: (2011)

Cardiac dysfunction among soft tissue sarcoma patients in Denmark
por: Shantakumar, Sumitra, et al.
Publicado: (2016)

Checkpoint Inhibition in Bladder Cancer: Clinical Expectations, Current Evidence, and Proposal of Future Strategies Based on a Tumor-Specific Immunobiological Approach
por: Mancini, Mariangela, et al.
Publicado: (2021)

Targeting tumors with a killer-reporter adenovirus for curative fluorescence-guided surgery of soft-tissue sarcoma
por: Yano, Shuya, et al.
Publicado: (2015)

Characterization of tumor infiltrating Natural Killer cell subset
por: Levi, Inbar, et al.
Publicado: (2015)

Next-generation dendritic cells for immunotherapy of acute myeloid leukemia
por: Schnorfeil, Frauke, et al.
Publicado: (2014)

Estimating proportions of explained variance: a comparison of whole genome subsets
por: Aslibekyan, Stella, et al.
Publicado: (2014)

Changes of proportions of circulating lymphocyte subsets in cancer patients after chemotherapy
por: Wang, Weimin, et al.
Publicado: (2021)

Turning tumor inhibition into activation: engineering T cells with chimeric signaling receptors
por: Schlenker, Ramona, et al.
Publicado: (2014)

Support lines and beam killers for large-size multiwire proportional chambers
por: Majewski,, et al.
Publicado: (1975)

Soft-tissue Sarcomas
por: Vodanovich, Domagoj Ante, et al.
Publicado: (2018)

Human soft tissue sarcomas harbor an intratumoral viral microbiome which is linked with natural killer cell infiltrate and prognosis
por: Perry, Lauren M, et al.
Publicado: (2023)

Liver natural killer cells: subsets and roles in liver immunity
por: Peng, Hui, et al.
Publicado: (2016)

Impaired natural killer cell subset phenotypes in human obesity
por: Bähr, Ina, et al.
Publicado: (2018)

Role of Distinct Natural Killer Cell Subsets in Anticancer Response
por: Stabile, Helena, et al.
Publicado: (2017)

Frequency and phenotype of natural killer cells and natural killer cell subsets in bovine lymphoid compartments and blood
por: Hamilton, Carly A., et al.
Publicado: (2017)

Co-Regulation of Immune Checkpoint PD-L1 with Interferon-Gamma Signaling is Associated with a Survival Benefit in Renal Cell Cancer
por: Hänze, Jörg, et al.
Publicado: (2020)

Effector Functions of Natural Killer Cell Subsets in the Control of Hematological Malignancies
por: Gismondi, Angela, et al.
Publicado: (2015)

The Diagnostic Utility of Natural Killer Cell Subsets in Deep Vein Thrombosis
por: Alhabibi, Alshaymaa M, et al.
Publicado: (2023)

Retroperitoneal soft tissue sarcoma
por: Zepeda, Ernesto, et al.
Publicado: (2007)

Trabectedin in Soft Tissue Sarcomas
por: Petek, Bradley J., et al.
Publicado: (2015)

Soft Tissue Sarcomas of the Kidney
por: Köhle, Olivia, et al.
Publicado: (2015)

Case of Soft Sarcoma of the Cerebellum
por: Steven, James
Publicado: (1870)

Bone and Soft Tissue Sarcoma
por: Ruggiero, Antonio
Publicado: (2020)

Trabectedin for soft tissue sarcoma
Publicado: (2021)

Elimination of syngeneic sarcomas in rats by a subset of T lymphocytes
Publicado: (1980)

Impact of Corticosteroids on the Proportions of Circulating Tfh Cell Subsets in Patients With Systemic Lupus Erythematous
por: Mao, Minjing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_57bkgodfp87iarse0de6a8163u